Warning: Declaration of subscribe2_widget::addPluginSubMenu() should be compatible with mijnpress_plugin_framework::addPluginSubMenu($title, $function, $file, $capability = 10, $where = 'plugins.ph...') in /data/32/2/10/97/2499423/user/2737425/htdocs/wordpress1/wp-content/plugins/subscribe2-widget/subscribe2-widget.php on line 18

Warning: Declaration of subscribe2_widget::addPluginContent($links, $file) should be compatible with mijnpress_plugin_framework::addPluginContent($filename, $links, $file, $config_url = NULL) in /data/32/2/10/97/2499423/user/2737425/htdocs/wordpress1/wp-content/plugins/subscribe2-widget/subscribe2-widget.php on line 18
Women In Life Sciences Panel Announced | SEBIO

Women In Life Sciences Panel Announced

Posted by on Oct 3, 2019

Join a truly remarkable group of senior level women executives from the life sciences industry for substantive remarks around the perpetually evolving life sciences industry at the SEBIO Investor & Partnering Forum on Thursday, November 7. The speed and magnitude of this evolution continues to hasten every year and likewise the role of women in the life sciences industry is continuing to evolve. The accomplishments of women in this field are being recognized more and more, and this momentum is leading to more seats in corner offices and at boardroom tables. Women fill half of the industry’s entry-level positions but make up only 20% of leadership teams and 10% of boards, thus there is much work to yet be done.

Women In Life Sciences.jpg

Sue Washer, President and CEO of AGTC will moderate this important discussion. Lending their thoughts will be panelists Heather Behanna, PhD, an Investment Consultant for SR One in the San Francisco Bay area and previous Principal at Sofinnova Investments; Carol A. Schafer, Managing Partner of Hyphen Advisors, LLC and a seasoned financial professional with more than 25 years of experience in investment banking and equity capital markets, as well as corporate finance and business development in the biopharmaceutical sector and most recently served as Vice Chair, Equity Capital Markets at Wells Fargo Securities; and Cynthia (Cindy) Collins, President and CEO of Editas Medicine. Cindy is a recognized leader in gene and cell medicines, molecular diagnostics, life sciences, and therapeutics. Prior to joining Editas, Cindy served as the CEO of Human Longevity, Inc. She also served as the CEO/GM of the Cell Therapy and Lab Business of General Electric’s Healthcare Life Sciences and as the CEO of Clarient Diagnostics, Inc.; as President and CEO of GenVec, Inc., a publicly-traded vaccine and gene therapy company; as Group Vice President, Cellular Analysis Business of Beckman Coulter; and as President and CEO of Sequoia Pharmaceuticals, Inc., a venture-capital funded company developing antiviral drugs for HIV and HCV.

Leave a Reply